ARTICLES BY ALEXANDER K. AUST

  • nanoparticles-drug molecule-GettyImages-1428647836
    Tracking 4 Payload Trends In Drug Delivery Development
    1/22/2024

    Amid new research and development in nanocarriers, market attention has shifted toward payloads and enhancing compatibility. This discussion explores the latest trends and includes a research database.

  • T Cell GettyImages-538032878
    6 PEG Alternatives You Should Be Thinking About
    11/22/2023

    PEGylation is a common way to minimize off-target effects and general toxicity, but it also poses life-threatening risks because it prolongs the drug's time in the bloodstream. Scientists are exploring these alternatives to combat the risk.

Headshot_AlexanderAust

Alexander K. Aust

Alexander K. Aust, M.S., MBA, is the co-founder and owner of Aust Business Solutions, a pharmaceutical consultancy based in Maryville, Tennessee. The firm specializes in the manufacture of cell and gene therapies and sterile, parenteral drug products with services including facility design and construction, corporate strategy, marketing, business development, market research, project management, technology transfers, CDMO selection, quality audits, supply chain management, and process development of drug delivery systems. The firm has helped companies increase capabilities and capacities related to mRNA-LNP formulation, testing, and cGMP manufacturing. The firm has also established and qualified cGMP drug product and biologics facilities that can manufacture preclinical, clinical, and commercial drugs to meet global regulatory requirements. Aust earned his MBA from Ball State University and an M.S. degree from Purdue University in molecular and cellular biology.